Balistreri, C.R.; Magro, D.; Scola, L.; Aridon, P.; Ragonese, P.; Dos Santos Mendes, F.A.; Schirò, G.; D’Amelio, M.
Shed Syndecans (1–3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson’s Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel. Int. J. Mol. Sci. 2025, 26, 4503.
https://doi.org/10.3390/ijms26104503
AMA Style
Balistreri CR, Magro D, Scola L, Aridon P, Ragonese P, Dos Santos Mendes FA, Schirò G, D’Amelio M.
Shed Syndecans (1–3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson’s Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel. International Journal of Molecular Sciences. 2025; 26(10):4503.
https://doi.org/10.3390/ijms26104503
Chicago/Turabian Style
Balistreri, Carmela Rita, Daniele Magro, Letizia Scola, Paolo Aridon, Paolo Ragonese, Felipe Augusto Dos Santos Mendes, Giuseppe Schirò, and Marco D’Amelio.
2025. "Shed Syndecans (1–3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson’s Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel" International Journal of Molecular Sciences 26, no. 10: 4503.
https://doi.org/10.3390/ijms26104503
APA Style
Balistreri, C. R., Magro, D., Scola, L., Aridon, P., Ragonese, P., Dos Santos Mendes, F. A., Schirò, G., & D’Amelio, M.
(2025). Shed Syndecans (1–3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson’s Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel. International Journal of Molecular Sciences, 26(10), 4503.
https://doi.org/10.3390/ijms26104503
